ctrl K

Price Alert

Cullinan Oncology Inc. (CGEM)

NASDAQ: CGEM · Real-Time Price · USD

7.95

0.29 (3.79%)

At close: Aug 18, 2025, 3:59 PM

7.95

0.00%

After-hours: Aug 18, 2025, 04:10 PM EDT

Cullinan Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	83M	98.43M	156.15M	59.77M
Short-Term Investments	315.97M	368.63M	311.14M	230.69M
Long-Term Investments	204.44M	n/a	80.88M	140.4M
Other Long-Term Assets	366K	459K	459K	147K
Receivables	3M	5.4M	n/a	n/a
Inventory	n/a	-5.4M	n/a	n/a
Other Current Assets	12.69M	n/a	n/a	n/a
Total Current Assets	414.67M	480.19M	474.47M	296.56M
Property-Plant & Equipment	2.35M	3.53M	5.3M	77K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	207.16M	3.99M	86.64M	140.62M
Total Assets	621.82M	484.18M	561.12M	437.19M
Account Payables	1.68M	2.49M	2.66M	3.17M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	1.3M	1.44M	178K	n/a
Other Current Liabilities	135K	15.78M	1.96M	973K
Total Current Liabilities	30.65M	28.14M	22.5M	11.75M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	65K
Total Long-Term Liabilities	849K	2.15M	3.59M	65K
Total Liabilities	31.5M	30.29M	26.09M	11.81M
Total Debt	2.15M	3.59M	5.19M	n/a
Common Stock	6K	4K	5K	4K
Retained Earnings	-368.24M	-200.86M	-47.7M	-158.91M
Comprehensive Income	-133K	-129K	-2.6M	-838K
Shareholders Equity	590.33M	453.7M	535.03M	424.97M
Total Investments	520.41M	368.63M	392.02M	371.09M